# A Phase Ⅰ Clinical Study of GEN-725 Tablets in Patients With Advanced Solid Tumors

> **NCT07229898** · PHASE1 · RECRUITING · sponsor: **Henan Genuine Biotech Co., Ltd.** · enrollment: 48 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** GEN-725 tablets

## Key facts

- **NCT ID:** NCT07229898
- **Lead sponsor:** Henan Genuine Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-07
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07229898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07229898, "A Phase Ⅰ Clinical Study of GEN-725 Tablets in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07229898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*